CAPTRUST Financial Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Sell	23,882 -2,603	-10%	-$132K	﹤0.01%	1648
2026 Q1	$1.41M	Buy	26,485 +1,329	+5%	+$78K	﹤0.01%	1401
2025 Q4	$1.56M	Sell	25,156 -616	-2%	-$38K	﹤0.01%	1218
2025 Q3	$1.55M	Buy	25,772 +4,786	+23%	+$293K	﹤0.01%	1166
2025 Q2	$1.31M	Sell	20,986 -649	-3%	-$39K	﹤0.01%	1199
2025 Q1	$1.3M	Buy	21,635 +2,275	+12%	+$141K	﹤0.01%	1135
2024 Q4	$1.13M	Sell	19,360 -397	-2%	-$23.6K	﹤0.01%	1165
2024 Q3	$1.17M	Buy	19,757 +619	+3%	+$35.4K	﹤0.01%	1098
2024 Q2	$1.07M	Sell	19,138 -327	-2%	-$18.3K	﹤0.01%	1099
2024 Q1	$1.14M	Buy	19,465 +2,224	+13%	+$126K	﹤0.01%	1059
2023 Q4	$930K	Sell	17,241 -1,884	-10%	-$92K	﹤0.01%	1313
2023 Q3	$928K	Buy	19,125 +801	+4%	+$42.6K	﹤0.01%	1249
2023 Q2	$1.03M	Sell	18,324 -398	-2%	-$21.9K	﹤0.01%	1183
2023 Q1	$1.01M	Sell	18,722 -277	-1%	-$14.7K	﹤0.01%	1031
2022 Q4	$999K	Buy	18,999 +1,269	+7%	+$64.4K	0.01%	974
2022 Q3	$836K	Sell	17,730 -2,284	-11%	-$119K	﹤0.01%	1004
2022 Q2	$1.01M	Buy	20,014 +1,618	+9%	+$88.2K	0.01%	834
2022 Q1	$1.12M	Sell	18,396 -1,897	-9%	-$113K	0.01%	800
2021 Q4	$1.34M	Buy	20,293 +1,921	+10%	+$123K	0.01%	690
2021 Q3	$1.15M	Buy	18,372 +4,806	+35%	+$307K	0.01%	700
2021 Q2	$816K	Buy	13,566 +1,074	+9%	+$62.1K	0.01%	803
2021 Q1	$688K	Buy	12,492 +120	+1%	+$6.66K	0.01%	832
2020 Q4	$675K	Buy	12,372 +624	+5%	+$32.6K	0.01%	736
2020 Q3	$585K	Buy	11,748 +822	+8%	+$39.8K	0.01%	671
2020 Q2	$484K	Buy	10,926 +6,096	+126%	+$261K	0.01%	717
2020 Q1	$171K	Hold	4,830	–	–	﹤0.01%	921
2019 Q4	$214K	Hold	4,830	–	–	﹤0.01%	958
2019 Q3	$199K	Buy	4,830 +2,400	+99%	+$98.3K	0.01%	573
2019 Q2	$97K	Buy	+2,430	New	+$92K	﹤0.01%	773

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

CAPTRUST Financial Advisors's IHI Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 9.8% in Q2 2026, selling an estimated $132K and leaving 23,882 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

CAPTRUST Financial Advisors first reported a position in IHI in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.56M in Q4 2025. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

CAPTRUST Financial Advisors held 23,882 shares of iShares US Medical Devices ETF worth $1.18M as of Q2 2026.
CAPTRUST Financial Advisors sold 2,603 iShares US Medical Devices ETF shares in Q2 2026, an estimated $132K.
iShares US Medical Devices ETF made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1648 holding.
CAPTRUST Financial Advisors first reported a position in iShares US Medical Devices ETF in Q2 2019 and has held it in 29 quarters since.
CAPTRUST Financial Advisors's iShares US Medical Devices ETF position peaked at $1.56M in Q4 2025.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.